Inflammatory Markers and the Metabolic Syndrome: Insights From Therapeutic Interventions

This publication has 79 references indexed in Scilit:

• Vascular and Metabolic Effects of Combined Therapy With Ramipril and Simvastatin in Patients With Type 2 Diabetes
  Hypertension, 2005
• Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome
  JAMA, 2004
• Simvastatin Combined With Ramipril Treatment in Hypercholesterolemic Patients
  Hypertension, 2004
• Comparison of effects of losartan, irbesartan, and candesartan on flow-mediated brachial artery dilation and on inflammatory and thrombolytic markers in patients with systemic hypertension
  The American Journal of Cardiology, 2004
• Vascular effects of diet and statin in hypercholesterolemic patients
  International Journal of Cardiology, 2004
• Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events
  Current Opinion in Cardiology, 2003
• Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential Hypertension
  Hypertension, 2003
• Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease
  Circulation, 2003
• Accumulation of LDL in Rat Arteries Is Associated With Activation of Tumor Necrosis Factor-α Expression
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Acute-Phase Proteins and Other Systemic Responses to Inflammation
  New England Journal of Medicine, 1999